Parl FF - Search Results

1

Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells.

Ottaviano YL, Issa JP, Parl FF, Smith HS, Baylin SB, Davidson NE. Ottaviano YL, et al. Among authors: parl ff. Cancer Res. 1994 May 15;54(10):2552-5. Cancer Res. 1994. PMID: 8168078

2

Mapping of ER gene CpG island methylation-specific polymerase chain reaction.

Lapidus RG, Nass SJ, Butash KA, Parl FF, Weitzman SA, Graff JG, Herman JG, Davidson NE. Lapidus RG, et al. Among authors: parl ff. Cancer Res. 1998 Jun 15;58(12):2515-9. Cancer Res. 1998. PMID: 9635570

3

Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors.

Lapidus RG, Ferguson AT, Ottaviano YL, Parl FF, Smith HS, Weitzman SA, Baylin SB, Issa JP, Davidson NE. Lapidus RG, et al. Among authors: parl ff. Clin Cancer Res. 1996 May;2(5):805-10. Clin Cancer Res. 1996. PMID: 9816234

4

Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer.

Nass SJ, Herman JG, Gabrielson E, Iversen PW, Parl FF, Davidson NE, Graff JR. Nass SJ, et al. Among authors: parl ff. Cancer Res. 2000 Aug 15;60(16):4346-8. Cancer Res. 2000. PMID: 10969774

5

Estrogen receptor genotypes and haplotypes associated with breast cancer risk.

Gold B, Kalush F, Bergeron J, Scott K, Mitra N, Wilson K, Ellis N, Huang H, Chen M, Lippert R, Halldorsson BV, Woodworth B, White T, Clark AG, Parl FF, Broder S, Dean M, Offit K. Gold B, et al. Among authors: parl ff. Cancer Res. 2004 Dec 15;64(24):8891-900. doi: 10.1158/0008-5472.CAN-04-1256. Cancer Res. 2004. PMID: 15604249

6

Binding analysis of the estrogen receptor to its specific DNA target site in human breast cancer.

Foster BD, Cavener DR, Parl FF. Foster BD, et al. Among authors: parl ff. Cancer Res. 1991 Jul 1;51(13):3405-10. Cancer Res. 1991. PMID: 2054780

7

Genomic DNA analysis of the estrogen receptor gene in breast cancer.

Parl FF, Cavener DR, Dupont WD. Parl FF, et al. Breast Cancer Res Treat. 1989 Oct;14(1):57-64. doi: 10.1007/BF01805976. Breast Cancer Res Treat. 1989. PMID: 2575000

8

Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood.

Yaich L, Dupont WD, Cavener DR, Parl FF. Yaich L, et al. Among authors: parl ff. Cancer Res. 1992 Jan 1;52(1):77-83. Cancer Res. 1992. PMID: 1345763

9

Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer.

Roodi N, Bailey LR, Kao WY, Verrier CS, Yee CJ, Dupont WD, Parl FF. Roodi N, et al. Among authors: parl ff. J Natl Cancer Inst. 1995 Mar 15;87(6):446-51. doi: 10.1093/jnci/87.6.446. J Natl Cancer Inst. 1995. PMID: 7861463

10

p53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment.

Caleffi M, Teague MW, Jensen RA, Vnencak-Jones CL, Dupont WD, Parl FF. Caleffi M, et al. Among authors: parl ff. Cancer. 1994 Apr 15;73(8):2147-56. doi: 10.1002/1097-0142(19940415)73:8<2147::aid-cncr2820730820>3.0.co;2-5. Cancer. 1994. PMID: 8156519

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters